等待開盤 10-21 09:30:00 美东时间
0.000
NaN.00%
Rapid induction with SUBLOCADE® showed higher treatment retention rates compared to standard induction, particularly among fentanyl-positive participantsRICHMOND, Va., Oct. 15, 2025 /PRNewswire/ -- Indivior PLC
10-15 20:07
RICHMOND, Va., Oct. 1, 2025 /PRNewswire/ -- Indivior PLC (Nasdaq: INDV) ("Indivior PLC" or the "Company") today announced that it intends to pursue a change in domicile from the U.K. to the ...
10-01 20:00
<p>Northrop Grumman Corporation announced that its third quarter 2025 financial results will be released on October 21, 2025, prior to market opening. The earnings announcement and presentation will be available on the company’s investor relations website. A live audio-only earnings call webcast will be held at 9:30 a.m. ET the same day, with a replay available shortly after. Northrop Grumman is a leading aerospace and defense technology company,...
09-18 13:04
RICHMOND, Va., June 24, 2025 /PRNewswire/ -- Indivior PLC (Nasdaq / LSE: INDV) today announced the appointment of Tony Kingsley to the Board of Directors as an Independent Non-Executive Dire...
06-25 04:12
A post-hoc analysis demonstrates that buprenorphine exposure with 300 mg SUBLOCADE® (buprenorphine extended-release) may improve treatment outcomes among opioid use disorder (OUD) patients with heavy fentanyl
06-19 21:02
In further consideration of Indivior's listing structure, the Board now believes that the London Delisting will be beneficial for the following reasons:Fully aligns with Indivior's most attractive and valuable
06-02 14:05
Seasoned commercial executive with more than 30 years of pharmaceutical experience RICHMOND, Va., May 27, 2025 /PRNewswire/ -- Indivior PLC (Nasdaq/LSE: INDV) today announced the appointment...
05-27 20:30
Rapid Initiation Protocol Reduces Time to Treatment with SUBLOCADE® From One Week to One Hour, A Significant Advancement in the Treatment of Moderate to Severe Opioid Use Disorder (OUD) RICH...
02-24 15:00
Earnings Call Insights: Indivior PLC (NASDAQ:INDV) Q4 2024 Management View The CEO highlighted that 2024 ended with SUBLOCADE achieving 20% net revenue growth despite challenges, including competition...
02-21 03:27
格隆汇10月24日|英国药品集团Indivior(INDV.US)盘前涨超8%。该公司第三季度表现出色,净收入增长13%至3.07亿美元,主要SUBLOCAD...
2024-10-24 17:27